Hemay020
Hemay020P1 2014
Phase 1 small_molecule terminated
Quick answer
Hemay020 for Neoplasms，Non-Small Cell Lung Cancer is a Phase 1 program (small_molecule) at Tianjin Hemay Pharmaceutical Co., Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tianjin Hemay Pharmaceutical Co., Ltd
- Indication
- Neoplasms，Non-Small Cell Lung Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated